Skip to main content

Wellington Management — Portfolio, Page 12

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

276
Companies
$67.6B
Total invested
$257.2M
Avg. check
38
Industries
Biotechnology 6Health Care 5Consumer Goods 2E-Commerce 2Developer Platform 2Software 2+32 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 265276 of 276
Coupang
January 2021

Coupang is an e-commerce platform that offers a wide variety of products, including apparel, electronics, and home goods.

Apparel · SeoulPost Ipo Equity
Skillz
December 2020

Skillz is a marketplace platform for competition-based mobile games.

Developer Platform · Las Vegas$159.0M Post Ipo Equity
LianBio
October 2020

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

Biopharma · Shanghai$310.0M Series A
ACV
September 2020

ACV is a full-service dealer marketplace that runs online automotive auctions.

Apps · Buffalo$55.0M Series E
PMV Pharmaceuticals
August 2020

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Biopharma · Redwood City$70.0M Series D
Atreca
July 2020

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

Biotechnology · South San Francisco$125.0M Post Ipo Equity
Forty Seven
August 2019

Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.

Biotechnology · Palo Alto$6.0M Post Ipo Equity
The Honest Company
June 2018

The Honest Company is a consumer products company that offers baby, personal care, and beauty products.

Baby · Santa Monica$200.0M Private Equity
Neon Therapeutics
December 2017

NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.

Bioinformatics · Cambridge$36.0M Series B
Nightstar Therapeutics
June 2017

Nightstar is biopharmaceutical company, focused on developing gene therapies for retinal dystrophies.

Biotechnology · London$45.0M Series C
Rhythm Metabolic
August 2015

Rhythm Metabolic develops a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies.

Developer Platform · Boston$40.0M Series A
Nanigans
March 2015

Nanigans provides an advertising automation software that powers the in-house performance marketing teams.

Advertising · Boston$24.0M Series B

Where Wellington Management invests

Biotechnology6
Health Care5
Consumer Goods2
E-Commerce2
Developer Platform2
Software2

About Wellington Management's portfolio

How many companies has Wellington Management invested in?

Wellington Management has invested in 276 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Wellington Management invest in?

Wellington Management's top investment sectors include Biotechnology, Health Care, Consumer Goods, E-Commerce, Developer Platform. The firm invests across 38 different industry categories.

What is Wellington Management's largest investment?

Among tracked funding rounds, LianBio received $310.0M in a Series A round. Wellington Management's total known invested capital is $67.6B.

What is the average investment size for Wellington Management?

Wellington Management's average investment size is $257.2M across its portfolio of 276 companies.

What are Wellington Management's most recent investments?

Recent Wellington Management portfolio additions include Coupang, Skillz, LianBio, ACV, PMV Pharmaceuticals. These companies were founded in 2020 or later.

Reach the founders behind these 276 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →